Show simple item record

dc.contributor.authorSmuts, Corneliusen_US
dc.contributor.authorHon, G.M.
dc.contributor.authorHassan, M.S.
dc.contributor.authorVan Rensburg, S.J.
dc.contributor.authorAbel, S.
dc.contributor.authorMarais, D.W.
dc.contributor.authorVan Jaarsveld, P.
dc.contributor.authorHenning, F.
dc.contributor.authorErasmus, R.T.
dc.contributor.authorMatsha, T.
dc.date.accessioned2010-08-04T15:36:01Z
dc.date.available2010-08-04T15:36:01Z
dc.date.issued2009en_US
dc.identifier.citationSmuts, C. et al. 2009. Erythrocyte membrane fatty acids in patients with multiple sclerosis. Multiple Sclerosis, 15(6):759-62, Jun. [https://doi.org/10.1177/1352458509103321]en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/3336
dc.identifier.urihttps://doi.org/10.1177/1352458509103321
dc.description.abstractBACKGROUND: Reports on fatty acids levels in multiple sclerosis remain inconclusive. OBJECTIVE: To determine the erythrocyte membrane fatty acid levels in multiple sclerosis patients and correlate with Kurtzke Expanded Disability Status Scale. METHODS: Fatty acid composition of 31 multiple sclerosis and 30 control individuals were measured by gas chromatography. RESULTS: The membrane phosphatidylcholine C20:4n - 6 concentration was lower in the multiple sclerosis patients when compared to that of the control group, P = 0.04 and it correlated inversely with the EDSS and FSS. CONCLUSION: Decrease in C20:4n - 6 in the erythrocyte membrane could be an indication of depleted plasma stores, and a reflection of disease severity.
dc.publisherSAGE Publications
dc.titleErythrocyte membrane fatty acids in patients with multiple sclerosisen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record